Both stimulate endogenous GH secretion — but they have different structures, half-lives, clinical data, and research applications. Here's how to think about the choice.
Both sermorelin and tesamorelin are GHRH analogs that stimulate endogenous GH secretion, but they were developed for different purposes and have meaningfully different profiles. Sermorelin is a shorter fragment with a rapid pulse, extensive pediatric clinical data, and broad GH-deficiency research applications. Tesamorelin is a stabilized full-length GHRH analog with FDA approval specifically for visceral adiposity in HIV-associated lipodystrophy, backed by randomized controlled trial data for visceral fat reduction.
Sermorelin is GHRH(1-29)-NH₂ — the 29-amino-acid N-terminal fragment of endogenous GHRH, amidated at the C-terminus. This fragment retains full GHRH receptor binding activity. The shorter sequence makes it faster to clear and produces a sharp, pulsatile GH response.
Tesamorelin is a synthetic analog of the full 44-amino-acid GHRH, modified with a trans-3-hexenoic acid group at the N-terminus. This modification substantially increases resistance to dipeptidyl peptidase IV (DPP-IV) degradation, extending its half-life from about 7 minutes (native GHRH) to approximately 26 minutes. The result is a longer, more sustained GH stimulus per injection.
Endogenous GHRH is rapidly cleaved by DPP-IV. Tesamorelin's N-terminal modification specifically blocks this cleavage site, explaining its longer half-life and the more sustained IGF-1 response seen in clinical trials versus sermorelin.
| Factor | Sermorelin | Tesamorelin |
|---|---|---|
| Structure | GHRH(1-29)-NH₂ | GHRH(1-44) + trans-3-hexenoic acid |
| Half-life | ~11 minutes | ~26 minutes |
| GH response pattern | Sharp pulse | More sustained |
| IGF-1 increase | Moderate | More pronounced |
| FDA approval | GH deficiency (pediatric, 1997, discontinued) | HIV lipodystrophy visceral fat (2010, active) |
| Visceral fat data | Limited direct RCT data | Strong Phase 3 RCT data |
| Typical dose | 200–500 mcg/day | 2mg/day |
| Typical cycle | 3–6 months | 6–12 months |
| Cost | Lower | Higher |
| Clinical history | Extensive (pediatric) | Strong (adult visceral fat) |
Sermorelin has the deeper clinical history. Its pediatric GH deficiency data spans decades, with comparative trials against recombinant HGH showing similar height velocity outcomes. In adult somatopause research, sermorelin has demonstrated reliable IGF-1 restoration and body composition improvements over 6-month periods.
Tesamorelin's data is more targeted but arguably more rigorous for its specific application. The Phase 3 LIPO trials demonstrated a 15–18% reduction in visceral adipose tissue (VAT) over 26 weeks in HIV-positive subjects with lipodystrophy — the data package that earned FDA approval for Egrifta. Subsequent research has explored tesamorelin in non-HIV populations with visceral adiposity and in cognitive aging research (ongoing TREAT trial data).
The two compounds are more similar than different when used for general somatopause or GH optimization research. Tesamorelin produces higher, more sustained IGF-1 elevation; sermorelin produces a more physiological pulsatile pattern. Neither has been directly compared head-to-head in a rigorous RCT for this application.
| Research Goal | Lean Toward | Why |
|---|---|---|
| GH deficiency research | Sermorelin | More established literature, lower cost |
| Visceral fat reduction | Tesamorelin | Direct Phase 3 RCT data for this endpoint |
| GH pulsatility restoration | Sermorelin | Sharper, more physiological pulse pattern |
| IGF-1 optimization | Tesamorelin | More sustained IGF-1 elevation per dose |
| Cost-sensitive protocols | Sermorelin | Significantly lower cost per cycle |
| Longer half-life preferred | Tesamorelin | 26 min vs 11 min; less frequent peaks |
Some researchers have explored GHRH analogs alongside GHRP peptides (ipamorelin) regardless of which GHRH analog is used. The GHRH + GHRP synergy appears class-wide — meaning the combination effect applies to both sermorelin and tesamorelin protocols.
COA-verified vendor pricing, promo codes, and reconstitution guide.
View Pricing → Dosage Calculator